DEF 14A
FORM DEF 14A
- Company
- AIM ImmunoTech Inc.
- Filed
- May 25, 1999
- Period of Report
- July 14, 1999
- Accession Number
- 0000891092-99-000321
A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →